Journal rankings · indicator year 2002
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2002
Infectious Diseases journal rankings 2002
78 ranked journals · Subfield in Medicine
Infectious Diseases has 78 ranked journals in 2002. The median OJR rose 0.14 on 2001 to 0.82, below the world average of 1.00; Q1 starts at OJR 1.25. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and Annals of Internal Medicine.
Ranks and citation indicators: 2002. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1999–2001, the window the 2002 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery358
- Pulmonary and Respiratory Medicine133
- Public Health, Environmental and Occupational Health125
- Cardiology and Cardiovascular Medicine124
- Oncology96
- Epidemiology87
- Infectious Diseases78
- Psychiatry and Mental health74
- Radiology, Nuclear Medicine and Imaging65
- Neurology64
- Physiology62
- Endocrinology, Diabetes and Metabolism57
Show all 42 subfields
- Dermatology47
- Hematology47
- Orthopedics and Sports Medicine47
- Pediatrics, Perinatology and Child Health46
- Ophthalmology42
- Obstetrics and Gynecology36
- Nephrology26
- Pharmacology26
- Rheumatology25
- Emergency Medicine23
- Reproductive Medicine22
- Otorhinolaryngology18
- Complementary and alternative medicine16
- Pathology and Forensic Medicine15
- Rehabilitation15
- Geriatrics and Gerontology13
- Immunology and Allergy13
- Critical Care and Intensive Care Medicine11
- Anesthesiology and Pain Medicine9
- Genetics8
- Hepatology7
- Gastroenterology6
- Urology5
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
78 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2001. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1999–2001, the window the 2002 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1999–2001 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2002. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 9.35Q1 | 17.18 2.64 up from 2001 | 2,525 | 25% | — | ||
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 6.61Q1 | 10.14 1.29 up from 2001 | 142 | 100% | — | ||
3Annals of Internal MedicineAmerican College of Physicians · United States | 3.33Q1 | 5.96 0.66 up from 2001 | 1,408 | 1% | — | ||
4Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.58Q1 | 3.73 1.59 down from 2001 | 671 | 100% | — | ||
5The Lancet Infectious DiseasesElsevier BV · Netherlands | 2.48Q1 | 4.17no 2001 value | 36 | 5% | $7,280 | — | |
6Clinical Infectious DiseasesOxford University Press · United States | 2.35Q1 | 4.46 0.43 up from 2001 | 1,894 | 27% | $4,763 | ||
7The Journal of Infectious DiseasesOxford University Press · United States | 2.34Q1 | 5.22 0.08 up from 2001 | 1,958 | 34% | $4,763 | ||
8AIDSLippincott Williams & Wilkins · United Kingdom | 2.10Q1 | 5.10 0.46 down from 2001 | 1,545 | 5% | — | ||
9Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.94Q1 | 4.56 0.17 up from 2001 | 1,923 | 100% | — | ||
10Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.79Q1 | 3.69 0.10 down from 2001 | 2,785 | 98% | — | ||
11Reviews in Medical VirologyWiley · United Kingdom | 1.59Q1 | 4.15 0.90 up from 2001 | 102 | 2% | $4,880 | ||
12Journal of General VirologyMicrobiology Society · United Kingdom | 1.56Q1 | 3.57 0.33 up from 2001 | 972 | 7% | — | ||
13Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.53Q1 | 2.99 0.12 down from 2001 | 1,127 | 26% | $3,784 | ||
14Tubercle and Lung DiseaseChurchill Livingstone · United Kingdom | 1.51Q1 | 2.52 0.16 up from 2001 | 58 | — | — | ||
15Microbes and InfectionElsevier BV · France | 1.45Q1 | 3.41 1.21 up from 2001 | 515 | 100% | $3,510 | ||
16Antiviral TherapyOASAGE Publishing · United Kingdom | 1.43Q1 | 4.05 0.76 up from 2001 | 98 | 57% | $2,800 | ||
17British Journal of Clinical PharmacologyWiley · United Kingdom | 1.40Q1 | 2.34 0.02 down from 2001 | 634 | 93% | $4,780 | ||
18AIDS Education and PreventionGuilford Press · United States | 1.39Q1 | 1.44 0.51 up from 2001 | 123 | 7% | — | ||
19AIDS CareTaylor & Francis · United Kingdom | 1.36Q1 | 1.86 0.31 down from 2001 | 112 | 6% | — | ||
20Journal of Medical VirologyWiley · United States | 1.25Q1 | 2.67 0.33 down from 2001 | 719 | 6% | $4,730 | ||
21Epidemiology and InfectionOACambridge University Press · United Kingdom | 1.23Q2 | 2.01 0.29 up from 2001 | 418 | 97% | $3,550 | ||
22American Journal of Infection ControlElsevier BV · United States | 1.19Q2 | 1.81 0.65 down from 2001 | 265 | 3% | $3,360 | ||
23TuberculosisElsevier BV · United Kingdom | 1.18Q2 | 1.95no 2001 value | 41 | 0% | $2,690 | — | |
24Diagnostic Microbiology and Infectious DiseaseElsevier BV · United States | 1.16Q2 | 1.97 0.31 down from 2001 | 404 | 2% | $3,290 | ||
25Tropical Medicine & International HealthWiley · United Kingdom | 1.14Q2 | 2.04 0.67 up from 2001 | 396 | 48% | $3,400 | ||
26International Journal of Medical MicrobiologyOAElsevier BV · Germany | 1.08Q2 | 2.06 0.67 up from 2001 | 162 | 2% | $3,410 | ||
27Antiviral ResearchElsevier BV · Netherlands | 1.06Q2 | 2.62 0.75 up from 2001 | 203 | 4% | $4,160 | ||
28Medical MycologyOxford University Press · United Kingdom | 1.01Q2 | 2.27 1.02 up from 2001 | 303 | 28% | $4,889 | ||
29Journal of Virological MethodsElsevier BV · Netherlands | 0.97Q2 | 2.06 0.26 up from 2001 | 466 | 7% | $3,210 | ||
30Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 0.97Q2 | 1.19 0.78 down from 2001 | 876 | 31% | $3,550 | ||
31Journal of Hospital InfectionElsevier BV · United Kingdom | 0.95Q2 | 1.75 0.25 down from 2001 | 548 | 2% | $4,000 | ||
32Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 0.95Q2 | 1.40 0.68 down from 2001 | 44 | 13% | $5,090 | ||
33JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 0.94Q2 | 2.39 0.53 up from 2001 | 1,170 | 2% | — | ||
34Virus ResearchOAElsevier BV · Netherlands | 0.91Q2 | 1.66 0.16 down from 2001 | 379 | 4% | $3,010 | ||
35HIV Clinical TrialsTaylor & Francis · United Kingdom | 0.89Q2 | 1.85 1.04 up from 2001 | 65 | 82% | — | ||
36ApmisWiley · United Kingdom | 0.88Q2 | 1.12 0.69 down from 2001 | 435 | 7% | $4,460 | ||
37Journal of Medical MicrobiologyMicrobiology Society · United Kingdom | 0.87Q2 | 1.73 0.07 up from 2001 | 269 | 7% | — | ||
38AIDS and BehaviorSpringer Science+Business Media · Netherlands | 0.86Q2 | 0.84 0.11 down from 2001 | 114 | 5% | $4,590 | ||
39Viral ImmunologyMary Ann Liebert, Inc. · United States | 0.85Q2 | 2.04 0.55 up from 2001 | 111 | 2% | — | ||
40Journal of InfectionOAElsevier BV · United Kingdom | 0.79Q3 | 1.49 0.32 up from 2001 | 377 | 2% | $4,030 | ||
41Clinics in Laboratory MedicineElsevier BV · United States | 0.76Q3 | 1.34 0.46 up from 2001 | 108 | 2% | $3,000 | ||
42FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 0.73Q3 | 1.50 0.11 up from 2001 | 519 | 41% | — | ||
43InfectionSpringer Science+Business Media · Germany | 0.72Q3 | 1.04 0.16 down from 2001 | 272 | 6% | $4,790 | ||
44AIDS Research and Human RetrovirusesMary Ann Liebert, Inc. · United States | 0.68Q3 | 2.45 0.14 down from 2001 | 660 | 5% | — | ||
45International Journal of Infectious DiseasesOAElsevier BV · Netherlands | 0.67Q3 | 0.81 0.58 down from 2001 | 139 | 100% | $2,900 | ||
46Scandinavian Journal of Infectious DiseasesInforma · United Kingdom | 0.66Q3 | 1.00 0.09 down from 2001 | 543 | 1% | — | ||
47MycopathologiaSpringer Science+Business Media · Netherlands | 0.60Q3 | 0.63 0.12 down from 2001 | 169 | 6% | $4,190 | ||
48HIV MedicineWiley · United Kingdom | 0.60Q3 | 1.30 0.14 up from 2001 | 81 | 55% | $4,150 | ||
49International Journal of STD & AIDSSAGE Publishing · United Kingdom | 0.59Q3 | 1.18 0.02 down from 2001 | 256 | 5% | $4,150 | ||
50AIDS Patient Care and STDsMary Ann Liebert, Inc. · United States | 0.57Q3 | 1.03 0.41 up from 2001 | 241 | 2% | — |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery358
- Pulmonary and Respiratory Medicine133
- Public Health, Environmental and Occupational Health125
- Cardiology and Cardiovascular Medicine124
- Oncology96
- Epidemiology87
- Infectious Diseases78
- Psychiatry and Mental health74
- Radiology, Nuclear Medicine and Imaging65
- Neurology64
- Physiology62
- Endocrinology, Diabetes and Metabolism57
- Dermatology47
- Hematology47
- Orthopedics and Sports Medicine47
- Pediatrics, Perinatology and Child Health46
- Ophthalmology42
- Obstetrics and Gynecology36
- Nephrology26
- Pharmacology26
- Rheumatology25
- Emergency Medicine23
- Reproductive Medicine22
- Otorhinolaryngology18
- Complementary and alternative medicine16
- Pathology and Forensic Medicine15
- Rehabilitation15
- Geriatrics and Gerontology13
- Immunology and Allergy13
- Critical Care and Intensive Care Medicine11
- Anesthesiology and Pain Medicine9
- Genetics8
- Hepatology7
- Gastroenterology6
- Urology5
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2002. Corpus-wide, 69.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
29 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1999–2001, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2002. Publication window: 1999–2001. How these summaries are calculated
- Ranked journals
- 78
- Window papers (baseline)
- 22,805 Change unavailable from indicator year 1999
- Median OJR
- 0.82 Change unavailable from indicator year 1999
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1999–2001 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.